- The Incidences of Malassezia in Steroid Acne and Other Acneiform Eruptions
-
Yu HJ, Kim YS, Yang HY, Kim JH, Lee SK, Son SJ
- KMID: 1855460
- Korean J Med Mycol.
- 1998 Jun;3(1):24-32.
BACKGROUND: Steroid acne is a folliculitis that can result from a systemic or topical administration of steroid and has been described as showing similar clinical pictures to Malassezia folliculitis, but... -
- CITED
-
- Close
- SHARE
-
- Close
- Dasatinib (Sprycel®)-Associated Acneiform Eruption Improved by Dose Reduction due to Pleural Effusion in a Patient with Chronic Myeloid Leukemia
-
Lim JH, Woo Y, Kim M, Park HJ
- KMID: 2436860
- Korean J Dermatol.
- 2018 Aug;56(7):472-474.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Acneiform Eruption Induced by Radotinib (IY5511 : HCL)
-
Chae WS, Jung HN, Seong JY, Suh HS, Choi YS
- KMID: 2089052
- Korean J Dermatol.
- 2014 Sep;52(9):679-680.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Acneiform Eruption Induced by Bevacizumab
-
Han SH, Kim JH, Oh YW, Kim DH, Choi YS, Suh HS
- KMID: 2446926
- Korean J Dermatol.
- 2019 Mar;57(3):159-161.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Acneiform Skin Eruption Associated with ZD1839(Iressa(R))
-
Kim YJ, Hwang KC, Yu DS, Oh CH, Song HJ
- KMID: 2086811
- Korean J Dermatol.
- 2004 Apr;42(4):478-481.
Epidermal growth factor (EGF) has an important role in the regulation of the proliferation and differentiation of epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of various... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Analysis of Drug Eruptions among Inpatients Seeking a Consultation with the Department of Dermatology
-
Lee MY, Byun JY, Choi HY, Choi YW
- KMID: 2436703
- Korean J Dermatol.
- 2018 Jun;56(5):314-321.
BACKGROUND: Drug eruptions are common in hospitalized patients. Rapid and accurate diagnosis is essential but often difficult. OBJECTIVE: This study defined the clinical features and causative drugs among inpatients presenting with... -
- CITED
-
- Close
- SHARE
-
- Close
- Cutaneous Adverse Effects Associated with Iressa(R)(Gefitinib) Medication
-
Park JH, Oh JJ, Choi YL, Kim WS, Lee JH, Lee ES
- KMID: 2302741
- Korean J Dermatol.
- 2005 Jan;43(1):92-95.
We report cutaneous adverse effects developed in three patients and are probably related to Iressa(R)(Gefitinib, ZD1839) medication. Iressa(R) is a new anti-cancer agent which acts by inhibiting epidermal growth factor... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Acneiform Eruption on the Healed Site of Herpes Zoster
-
Park SJ, Lee SH, Lee HG, Kim JM
- KMID: 2116016
- Korean J Dermatol.
- 1997 Oct;35(5):994-996.
The occurrence of a new skin disorder at t.he site of another unrelated and already healed skin disease is called an isotopic response. This was defined by Wolf et al... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Acneiform Eruption Induced by Erlotinib (Tarceva(R))
-
Kim YY, Kim SY
- KMID: 2248785
- Korean J Dermatol.
- 2007 Nov;45(11):1183-1186.
Erlotinib (Tarceva(R)) is a new anticancer agent, acting as a reversible tyrosine kinase inhibitor of the epidermal growth factor receptor. It blocks signal transduction pathways implicated in the proliferation and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa(R))
-
Yu DK, Suh DH, Youn JI
- KMID: 2302768
- Korean J Dermatol.
- 2004 Nov;42(11):1461-1465.
ZD1839 (Iressa(R)) is a new anticancer agent, a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that blocks signal transduction pathway implicated in the proliferation and survival of cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Acneiform Eruption Induced by Dacomitinib (PF-00299804)
-
Park SY, Suh DH
- KMID: 2301513
- Korean J Dermatol.
- 2015 May;53(4):324-327.
Dacomitinib (PF-00299804) is a newly developed irreversible pan-HER (human epidermal growth factor receptor) inhibitor for the treatment of non-small cell lung cancer (NSCLC). Inhibiting HER-1 (epidermal growth factor receptor, EGFR),... -
- CITED
-
- Close
- SHARE
-
- Close
- Severe Acneiform Eruption Induced by Cetuximab (Erbitux(R))
-
Lee JE, Lee SJ, Lee HJ, Lee JH, Lee KH
- KMID: 2158205
- Yonsei Med J.
- 2008 Oct;49(5):851-852.
- doi: 10.3349/ymj.2008.49.5.851
Epidermal growth factor has an important role in the regulation of proliferation and differentiation in epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of cancer cells. Cetuximab... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Acneiform Eruption Caused by Epidermal Growth Factor Receptor Inhibitors
-
Choi KW, Lee CY, Lee YK, Kim HS, Kim KH, Kim YH
- KMID: 2248163
- Korean J Dermatol.
- 2008 Jun;46(6):862-865.
Epidermal growth factor receptor (EGFR) inhibitors are associated with unique and dramatical dermatological side effects. The most commonly encountered adverse effect is a mild skin toxicity characterized by a sterile... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical Analysis of Drug Eruption
-
Kim JH, Kim MJ, Cho S, Whang KK, Hahm JH
- KMID: 1964828
- Ewha Med J.
- 1999 Dec;22(4):247-251.
- doi: 10.12771/emj.1999.22.4.247
OBJECTIVES AND METHOD: This study attempts to evaluate the clinical manifestations and causative drugs of drug eruptions at Ewha Womans University Tongdaemun Hospital by retrospective study of outpatients, inpatients and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Acneiform Eruption Occurring after Injection of Cetuximab (Erbitux(R), IMC-C225)
-
Choi YL, Lee KJ, Park HS, Kim WS, Lee JH, Yang JM, Lee ES, Lee DY
- KMID: 2249389
- Korean J Dermatol.
- 2005 Oct;43(10):1423-1425.
We report a case of acneiform skin eruption induced by cetuximab in a 58-year-old man. Cetuximab is a new anticancer agent, which acts as a selective epidermal growth factor receptor... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Paronychia, Acneiform Eruption and Dry Skin Induced by Iressa(R)
-
Bae EY, Kim MY, Kim HO, Park YM
- KMID: 2302905
- Korean J Dermatol.
- 2004 May;42(5):665-668.
Iressa(R) (ZD1839) is a new anticancer agent, acting as a selective epidermal growth factor receptor tyrosine kinase inhibitor. Iressa(R) has been generally well-tolerated in cancer patients. Predominant adverse effects are... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Study and Skin Tests of Patients with Drug Eruptions
-
Chang KY, Park HJ, Lim YS, Choi HY, Myung KB
- KMID: 2230519
- Korean J Dermatol.
- 1998 Dec;36(6):997-1004.
BACKGROUND: Drug reactions are common problems in hospital inpatients and outpatients. Reliable diagnosis is essential but often difficult. OBJECTIVE: This study attempts to define the clinical features and causative drugs... -
- CITED
-
- Close
- SHARE
-
- Close
- Malassezia Yeasts in Acne Vulgaris
-
Youn NH, Cha SH, Park SD
- KMID: 2038674
- Korean J Dermatol.
- 2002 Dec;40(12):1453-1460.
BACKGROUND: Acne is a common follicular inflammatory dermatoses affecting sebaceous glands. It has been known that Malassezia, the lipophilic normal human skin flora, contribute to the development of acne lesion,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Acneiform Eruption and Paronychia Occurring after Use of Erlotinib (Tarceva(R))
-
Yeon JH, Min SU, Lee DH, Choi YS, Suh DH
- KMID: 2248784
- Korean J Dermatol.
- 2007 Nov;45(11):1180-1182.
Erlotinib (Tarceva(R)) is a new anti-cancer agent which acts by inhibiting epidermal growth factor receptor (EGFR) signal transduction. It is currently used in the treatment of advanced stage non-small cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Features of the Cutaneous Adverse Events Induced by Combination Chemotherapy that Includes Cetuximab (Erbitux(R))
-
Chung WK, Chang SE, Ryu MH, Lee MW, Choi JH, Moon KC, Koh JK
- KMID: 2248022
- Korean J Dermatol.
- 2008 Nov;46(11):1478-1487.
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are associated with cutaneous adverse events, including papulopustular eruption, xerosis, paronychia, hair abnormality and mucositis. In particular, acneiform eruptions might serve as the... -
- CITED
-
- Close
- SHARE
-
- Close
